New GxP systems & automation
Establish intended use, GxP impact, validation strategy, requirements, supplier evidence and risk-based test scope before release.
Pune-based computerized system validation and digital-quality consulting with remote support worldwide, covering GxP systems, risk, traceability, data integrity and lifecycle governance.

Engagements may begin with a new GxP system, automation project, legacy-system remediation, data-integrity concern or lifecycle review where validation evidence and control need strengthening.
Establish intended use, GxP impact, validation strategy, requirements, supplier evidence and risk-based test scope before release.
Reconstruct lifecycle evidence, assess gaps and prioritise remediation where validation packages are incomplete, inconsistent or outdated.
Review access, roles, electronic records, audit trails, review practices and procedural controls supporting reliable GxP data.
Assess lifecycle changes, migration risk, backup/restore evidence and continued validated state before or after significant system change.
Support is tailored to your site, system, product context, risk profile and internal quality procedures.
Computerized-system assurance should be proportionate to intended use and GxP risk. Validation effort needs to focus on functions that can affect patient safety, product quality, data integrity and the reliability of regulated records.
We support lifecycle governance from system inventory and requirements through supplier evidence, testing, access and audit-trail controls, migration, release and periodic review.
Risk-based system inventory and GxP impact assessment to determine validation, data-integrity and lifecycle controls.
Validation strategy and planning based on intended use, system risk, supplier evidence and applicable requirements.
Risk-focused user requirements and end-to-end traceability from intended use through testing and release evidence.
Supplier and service-provider assessment covering quality systems, SDLC, support, security and relevant compliance evidence.
Documented assessment focused on patient safety, product quality, data integrity and intended use.
Review of test design, expected results, deviations and objective evidence for adequacy and traceability.
Review of user roles, privileged access, segregation, audit-trail configuration and review expectations.
Risk-based planning for migration verification, backup/restore testing, reconciliation and supporting evidence.
Periodic review of validated state, changes, incidents, access, audit trails, performance and supplier status.
Assessment and validation approach aligned, as applicable, with GAMP 5, FDA 21 CFR Part 11 and EU GMP Annex 11.
Digital validation is strongest when requirements, risk, supplier evidence, testing and operational controls remain connected throughout the system lifecycle.
Establish business purpose, users, records, interfaces, process context and functions that support regulated activity.
Determine whether the system can affect patient safety, product quality, data integrity or regulated records and decisions.
Focus assurance effort on critical functions, failure scenarios, controls and data with the greatest GxP significance.
Define risk-focused user requirements and connect critical requirements to specifications, controls and verification evidence.
Assess supplier capability and determine which existing development, configuration and test evidence can be leveraged appropriately.
Verify critical functions and controls using proportionate testing, objective evidence, deviation management and traceable results.
Confirm validation evidence, access controls, procedures, training, backup, support and residual actions before operational release.
Preserve the validated state through change control, incident review, access governance, periodic review and supplier oversight.
Deliverables are tailored to intended use, GxP impact, system complexity, supplier capability, client procedures and applicable regulatory requirements.
A computerized system whose intended use is defined, critical risks are understood, requirements and testing are traceable, regulated data is appropriately controlled and lifecycle decisions remain documented.
Start with the system’s intended use, GxP impact, configuration, interfaces, supplier support and lifecycle stage. Suitability for an engagement is assessed against the system and the evidence available, rather than assumed from a software name alone.
Planning, requirements, risk assessments, traceability, supplier evidence and test-document review can be supported remotely. System access, execution responsibilities, data protection and any site-dependent activities must be agreed with the client’s authorised teams.
Provide a high-level description of the system, business process, project stage, users and main concerns. Avoid sending credentials, production data or confidential records through the general enquiry form. Detailed evidence can follow after access and confidentiality arrangements are agreed.
Explore worldwide service coverageTell us your context and what outcome you need to achieve.
Work is scoped against applicable client procedures, regulatory requirements and guidance. Depending on the engagement, reference frameworks may include GxP, FDA 21 CFR requirements, EU GMP Annexes 1, 11 & 15, ICH Q9(R1), and ISO 9001:2015 quality-management principles.